Novartis to close deal for full ownership of Alcon

April 2010
Chain Drug Review;4/5/2010, Vol. 32 Issue 7, p31
Trade Publication
The article reports that Novartis AG will gain full ownership of Alcon Inc. in New York City after completing the agreement with Nestlé SA to acquire a 77% majority stake of Alcon and entering into an all-share direct merger for the remaining 23%.


Related Articles

  • Massachusetts Plan Contests Alcon Buyout. Giardina, Michael // Investment Management Weekly;1/12/2010, p3 

    The article reports on the lawsuit filed by the Massachusetts Bricklayers and Mason Trust Funds against Alcon, Novartis and Nestlé. The lawsuit covers a new-pending offer which allegedly discriminates against minority shareholders. Based on court documents filed in the New York district...

  • Strategic Acquisitions Still Getting Done. Platt, Gordon // Global Finance;May2008, Vol. 22 Issue 5, p91 

    The article reports on the acquisition of Alcon Inc. by Novartis AG for $39 billion in Switzerland. The purchase complements Novartis's Ciba Vision business and its Lucentis drug for treating macular degeneration in the elderly and Novartis will pay $11 billion to food company Nestlé for a...

  • Novartis becomes Alcon's majority owner. Webb, Jennifer A. // Ophthalmology Times;9/15/2010, Vol. 35 Issue 18, p1 

    The article reports on the 28.3 billion dollars acquisition of Nestle S.A.'s shares of Alcon Inc. by Novartis AG in Huenenberg, Switzerland. It states that the agreement requires the resignation of five designated members of Nestle from Alcon's board of directors. It notes that Thomas G....

  • Acquisitions Boost Sales Growth for Alcon in Q3 Fiscal Quarter.  // Vision Monday;11/15/2010, Vol. 24 Issue 13, p058 

    This article reports on the 9.0% growth in the global sales of Alcon Inc. during the third quarter of 2010. The growth can be attributed to revenue from acquisitions. Particular focus is given to the decline in the firm's third-quarter net earnings. In the U.S., the firm's sales increased by...

  • Alcon shareholders file suits. Webb, Jennifer A. // Ophthalmology Times;3/1/2010, Vol. 35 Issue 5, p1 

    The article offers information on the lawsuits filed by the minority shareholders of Alcon Inc., against the decision of Novartis AG to pay them less than it will pay Nestle SA. It mentions that most of the lawsuits have been filed in the U.S. District Court of the Southern District of the New...

  • TALK OF NESTL INTEREST LIFTS L'ORAL SHARES. Groves, Ellen // WWD: Women's Wear Daily;4/7/2008, Vol. 195 Issue 74, p4 

    The article reports on the increase in shares of Nestlé after market speculation that the company could buy out L'Oreal. The speculation intensified after announcement that Nestlé will sell a 24.85 percent stake in its Alcon eye care business to health care company Novartis. According to a...

  • Alcon's Irvine Operations Embrace Swiss Handover. Reed, Vita // Orange County Business Journal;8/11/2008, Vol. 31 Issue 32, p1 

    The article reports on the ownership change undergone by eye device and drug maker Alcon Inc. in Irvine, California. Drug maker Novartis AG took a 25% stake in Alcon from majority owner Nestlé SA and is expected to buy Nestlé's remaining 52% stake for about $28 billion by 2011. Kenneth...

  • Novartis, Alcon, finally resolve price issue for minority shares. PEDERSEN, AMANDA // Medical Device Daily;12/16/2010, Vol. 14 Issue 243, p1 

    The article reports on the agreement reached by Novartis and Alcon in December 2010 for the acquisition by the former of the remaining 23% of Alcon shares for 168 U.S. dollars a share. The other buyout deals entered by Novartis with Nestlé in 2008 and in August 2009 are briefly cited. The...

  • Novartis Finally Takes Control of Alcon.  // Chain Drug Review;9/27/2010, Vol. 32 Issue 16, p46 

    The article reports that Basel, Switzerland-based Novartis AG has achieved full control of eye care firm Alcon Inc. after it completed its 28.3 billion-dollar agreement with Nestlé SA.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics